John H Greist

Author PubWeight™ 28.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry 2002 6.02
2 Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial. Psychother Psychosom 2002 1.94
3 Feasibility and validation of a computer-automated Columbia-Suicide Severity Rating Scale using interactive voice response technology. J Psychiatr Res 2010 1.43
4 Assessing the onset of antidepressant-induced sexual dysfunction using interactive voice response technology. J Clin Psychiatry 2007 1.06
5 Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study. Curr Med Res Opin 2007 1.04
6 Prediction of suicidal behavior in clinical research by lifetime suicidal ideation and behavior ascertained by the electronic Columbia-Suicide Severity Rating Scale. J Clin Psychiatry 2013 1.01
7 A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode. Int Clin Psychopharmacol 2012 0.94
8 Is it easier to find what you are looking for if you think you know what it looks like? J Clin Psychopharmacol 2007 0.94
9 Validation of an IVRS version of the MADRS. J Psychiatr Res 2005 0.92
10 Telephonic Remote Evaluation of Neuropsychological Deficits (TREND): longitudinal monitoring of elderly community-dwelling volunteers using touch-tone telephones. Alzheimer Dis Assoc Disord 2007 0.91
11 An examination of 26,168 Hamilton Depression Rating Scale scores administered via interactive voice response across 17 randomized clinical trials. J Clin Psychopharmacol 2006 0.90
12 A pilot study of an electronic, adolescent version of the quick inventory of depressive symptomatology. J Clin Psychiatry 2007 0.89
13 The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial. J Clin Psychiatry 2006 0.89
14 A comparison of initial duloxetine dosing strategies in patients with major depressive disorder. J Clin Psychiatry 2007 0.86
15 A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder. J Clin Psychiatry 2003 0.83
16 St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study. Int Clin Psychopharmacol 2005 0.82
17 A novel interactive voice response (IVR) system for dementia screening, education, and referral: one-year summary. Alzheimer Dis Assoc Disord 2005 0.81
18 WCA recommendations for the long-term treatment of panic disorder. CNS Spectr 2003 0.80
19 Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study. J Clin Psychopharmacol 2002 0.79
20 Cost-effectiveness of computer-aided behaviour therapy for obsessive-compulsive disorder. Psychother Psychosom 2007 0.79
21 Using daily interactive voice response assessments: to measure onset of symptom improvement with duloxetine. Psychiatry (Edgmont) 2007 0.79
22 Voice response system to measure healthcare costs: a STAR*D report. Am J Manag Care 2009 0.78
23 Anchoring perceptions of clinical change on accurate recollection of the past: memory enhanced retrospective evaluation of treatment (MERET). Psychiatry (Edgmont) 2007 0.78
24 A randomized, double-blind study of increasing or maintaining duloxetine dose in patients without remission of major depressive disorder after initial duloxetine therapy. J Clin Psychiatry 2008 0.78
25 Duloxetine in practice-based clinical settings: assessing effects on the emotional and physical symptoms of depression in an open-label, multicenter study. Prim Care Companion J Clin Psychiatry 2007 0.75
26 Assessing onset of treatment benefit in depression and anxiety: conceptual considerations. J Clin Psychiatry 2009 0.75
27 WCA recommendations for the long-term treatment of social phobia. CNS Spectr 2003 0.75
28 Safety and tolerability of duloxetine in elderly patients with major depressive disorder: a pooled analysis of two placebo-controlled studies. Int Clin Psychopharmacol 2013 0.75
29 Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine. Ann Clin Psychiatry 2006 0.75